In a UK study, what percentage of bone tumors were malignant?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $25.99Unlock all

Study for the ACVIM Small Animal Internal Medicine Exam to enhance your veterinary knowledge. Prepare with flashcards and multiple-choice questions, featuring hints and explanations. Ensure success in your exam journey!

Multiple Choice

In a UK study, what percentage of bone tumors were malignant?

Explanation:
Interpreting study results involves looking at how many cases are malignant versus benign. In this UK study, about 73% of bone tumors were malignant, meaning roughly three out of four lesions were cancerous and the remaining portion (~27%) were benign. This reflects a tendency for bone tumors observed in veterinary patients to be predominantly malignant, which has practical implications: when a bone tumor is detected, there’s a high likelihood it’s malignant and prompts biopsy and staging to guide treatment. The other percentages would imply all tumors were malignant, none were malignant, or that only a quarter were malignant, which does not match the study’s finding.

Interpreting study results involves looking at how many cases are malignant versus benign. In this UK study, about 73% of bone tumors were malignant, meaning roughly three out of four lesions were cancerous and the remaining portion (~27%) were benign. This reflects a tendency for bone tumors observed in veterinary patients to be predominantly malignant, which has practical implications: when a bone tumor is detected, there’s a high likelihood it’s malignant and prompts biopsy and staging to guide treatment. The other percentages would imply all tumors were malignant, none were malignant, or that only a quarter were malignant, which does not match the study’s finding.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy